IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells - Wikidata - wikimedia - TriplyDB

IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells

IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells

http://www.wikidata.org/entity/Q35855291

about

Natural killer cells in infection and inflammation of the lung Natural killer cells from patients with chronic rhinosinusitis have impaired effector functions IL-18 does not increase allergic airway disease in mice when produced by BCG.Ozone exposed epithelial cells modify cocultured natural killer cells Serum interleukin-18 expression in children with bronchial asthma.Wheezing and itching: The requirement for STAT proteins in allergic inflammation Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma.NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation.Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.What's new in asthma pathophysiology and immunopathology?Therapeutic potential of STAT4 in autoimmunity.NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells.Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.

P2860

Q28391714-6AE16DD1-34A5-4B36-BCFD-9FA05EEAFCD8 Q35035078-234B1BC7-40CD-4712-AAD0-44F62839AF86 Q36449578-9225423F-9F8F-4D76-9BBB-9C8DEDC5EEA5 Q36699982-7B37624A-0318-4C2B-A328-E2BB27D06053 Q36834447-7F5DF094-04FC-4B10-9B48-0A700855489C Q36894976-1E9BA064-1387-48CE-BD0C-E8FE1244BA23 Q37251467-8354DD31-B65B-4BB3-AB52-3D90FE47B871 Q37296038-FA258FD2-0AF1-409E-93A4-5CAF11A2BC05 Q37296078-268D0F33-0D66-4C6C-9170-844E44543D80 Q37355888-87BCADCB-B689-433B-AE22-5ACF6467D4FD Q37798030-8CA75F68-B192-4A3E-B88C-9AD0FB385DC0 Q38213100-405DF3BB-20DC-4A14-AF9A-EE12A5759C0E Q38919669-28BF1156-3074-42EE-B6BF-0EA4BBC8D7BA Q45162906-79896621-018D-431A-9A3B-E45C937350DC

P2860

IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells

http://www.wikidata.org/entity/Q35855291

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@ast

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@en

type

label

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@ast

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@en

prefLabel

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@ast

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@en

P1433

Q35855291-D45A9FCC-98B3-498D-A66F-265B9D8A32AC

P1476

Q35855291-C73ED36E-0083-40AB-8402-6098CE4B3ED9

P2093

Q35855291-14BDA736-1AC0-410D-8F1B-5ABA3FBB7AE9

Q35855291-31DFC8BD-ACF5-44CB-80E6-1763467EBA92

Q35855291-40B37748-7052-43A2-89C2-7D0F4F806DFB

Q35855291-4B5A5BE0-ABB4-4254-93F3-627348C9266A

Q35855291-81A29C3F-311D-468E-B56A-B6096D3C7407

Q35855291-B6F8C604-0110-40F3-B10E-8B492BA5258A

Q35855291-CB56EA30-D246-459C-A4F5-C127A634DFD5

Q35855291-EB5911D6-3651-4423-9768-E86E51377BA9

P2860

Q35855291-07A89FE8-B598-4879-9D6D-3A9DDE019ACA

Q35855291-11A3A0C0-DABD-4350-85E5-BDED577F67B0

Q35855291-179F6053-CA0A-458A-BC9C-90390B5C788B

Q35855291-1AC328BE-41FB-4C2C-A3A8-3043A125D229

Q35855291-267CD890-E536-463A-A702-0E71F851A7B3

Q35855291-2CC6F1E0-EA8C-4412-8697-C3E3424B4D83

Q35855291-33E0B007-CDBA-4035-9B17-5F3F480F4595

Q35855291-40AC9BB8-74DD-4992-91D4-7D53A34DB484

Q35855291-4CCE9A4A-4D6A-4048-B537-B23331C5A10E

Q35855291-50F8AE2D-C855-4096-9428-77E3132CA9F8

P304

Q35855291-AB5F4009-52B3-4B76-A361-89D71BF636BE

P31

Q35855291-08CA2966-1945-4AE5-946C-B90BA4347D33

P356

Q35855291-7BE9CDE3-456B-4B6B-AC10-1E4F9BA2F2DE

P433

Q35855291-E34B390F-8C95-44E5-979D-571578205D9B

P478

Q35855291-40CCB8ED-94FB-424B-AF4F-5843C7419BB0

P50

Q35855291-051FD30D-8179-47CD-A16D-435CCF205314

Q35855291-6A4A8358-54D3-4ED8-9C6C-2B33E35AFD1F

P577

Q35855291-DAB57ACA-B814-4468-8208-2270B1C4124F

P698

Q35855291-173C7D5F-314B-44E4-84ED-D65640E0689C

P932

Q35855291-7B0CF66E-4ACE-44B3-AA25-43B0194F65E4

P356

RCMB.2006-0231OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

IL-2 and IL-18 attenuation of ...... amma, and natural killer cells

@en

P2093

Anthony Joetham

http://www.w3.org/2001/XMLSchema#string

Christina H Swasey

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Takeda

http://www.w3.org/2001/XMLSchema#string

Masakazu Okamoto

http://www.w3.org/2001/XMLSchema#string

Nobuaki Miyahara

http://www.w3.org/2001/XMLSchema#string

Shigeki Matsubara

http://www.w3.org/2001/XMLSchema#string

Taku Kodama

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Koya

http://www.w3.org/2001/XMLSchema#string

P2860

IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response

Interleukin-13: central mediator of allergic asthma

Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells

Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3

A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.

Immunologic basis of antigen-induced airway hyperresponsiveness.

Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.

Interleukin-18 regulates both Th1 and Th2 responses.

Overview of interleukin-2 function, production and clinical applications.

P304

324-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2006-0231OC

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Erwin W. Gelfand

Azzeddine Dakhama

P577

2006-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17038663

http://www.w3.org/2001/XMLSchema#string

P932

1899318

http://www.w3.org/2001/XMLSchema#string